Ngā hua rapu - Ye Peng
- E whakaatu ana i te 1 - 8 hua o te 8
-
1
Neuroinflammatory In Vitro Cell Culture Models and the Potential Applications for Neurological Disorders mā Ye Peng, Ye Peng, Shifeng Chu, Yantao Yang, Zhao Zhang, Zongran Pang, Naihong Chen, Naihong Chen, Naihong Chen
I whakaputaina 2021Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
2
Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients Wit... mā Haixia Zhang, Xiaohui Zeng, Ye Peng, Chongqing Tan, Xiaomin Wan
I whakaputaina 2022Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
3
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer mā Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan
I whakaputaina 2022Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
4
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review mā Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan
I whakaputaina 2022Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
5
Benefit-to-harm ratio and cost-effectiveness of government-recommended gastric cancer screening in China: A modeling study mā Shuxia Qin, Xuehong Wang, Sini Li, Sini Li, Chongqing Tan, Xiaohui Zeng, Meiyu Wu, Ye Peng, Liting Wang, Xiaomin Wan
I whakaputaina 2022Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
6
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer mā Xiaomin Wan, Xiaohui Zeng, Liubao Peng, Ye Peng, Qiao Liu, Lidan Yi, Xia Luo, Qijian Deng, Qijian Deng, Chongqing Tan
I whakaputaina 2021Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
7
Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis mā Ye Peng, Xiaohui Zeng, Liubao Peng, Qiao Liu, Lidan Yi, Xia Luo, Sini Li, Liting Wang, Shuxia Qin, Xiaomin Wan, Chongqing Tan
I whakaputaina 2022Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka -
8
Low-dose-rate induces more severe cognitive impairment than high-dose-rate in rats exposed to chronic low-dose γ-radiation mā Tianbao Ma, Tianbao Ma, Kexian Li, Wenjuan Sang, Xingyu Liu, Qun Luo, Ye Peng, Mingxing Wang, Xiu Luo, Jingjing Fang, Haijun Wang, Tao Wang, Changjing Zuo, Changjing Zuo
I whakaputaina 2024Tau karanga: E uta ana...Connect to this object online.
Tauwāhi: E uta ana...
Pukapuka